Bills · 2023-2024 Regular Session
Relating to: cost-sharing cap on epinephrine auto-injectors under health insurance policies and plans.
Drugs Insurance — Health Public employee — Group insurance
- Introduced, stopped here
- Passes Assembly, not reached
- Passes Senate, not reached
- Governor signs, not reached
- Law, not reached
Unfamiliar terms? Glossary
What this bill does
Plain-language analysis by the nonpartisan Legislative Reference Bureau
This bill prevents every health insurance policy and every self-insured
governmental health plan that covers medically necessary epinephrine
auto-injectors from imposing cost sharing in an amount that exceeds $60 for a
twin-pack of epinephrine auto-injectors, regardless of the type of epinephrine
auto-injector. Health insurance policies are referred to in the bill as disability
insurance policies.
This proposal may contain a health insurance mandate requiring a social and
financial impact report under s. 601.423, stats.
Sponsors
Full history
- Feb 2, 2024 · Assembly
Introduced by Representatives Subeck, Shankland, C. Anderson, J. Anderson, Conley, Considine, Drake, Emerson, Joers, Neubauer, Palmeri, Ratcliff, Sinicki and Stubbs; cosponsored by Senators Hesselbein, Spreitzer, Agard, Larson, Pfaff, Roys, Smith, Taylor and Wirch
- Feb 2, 2024 · Assembly
Read first time and referred to Committee on Insurance
- Feb 7, 2024 · Assembly
Commissioner of Insurance report received pursuant to s.601.423(2), Wisconsin Statutes
- Apr 15, 2024 · Assembly
Failed to pass pursuant to Senate Joint Resolution 1